Technical Analysis for GALT - Galectin Therapeutics Inc.

Grade Last Price % Change Price Change
grade B 5.06 6.75% 0.32
GALT closed up 6.75 percent on Friday, November 16, 2018, on 58 percent of normal volume. The stock crossed above its 200 day moving average, improving its long-term outlook by crossing above that critical trendline.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Up Down Up
See historical GALT trend table...

Date Alert Name Type % Chg
Nov 16 Crossed Above 200 DMA Bullish 0.00%
Nov 16 Wide Bands Range Expansion 0.00%
Nov 15 Crossed Above 20 DMA Bullish 6.75%
Nov 15 Inside Day Range Contraction 6.75%
Nov 15 Wide Bands Range Expansion 6.75%
Nov 14 Fell Below 20 DMA Bearish 9.52%
Nov 14 Wide Bands Range Expansion 9.52%
Nov 13 200 DMA Resistance Bearish 6.98%
Nov 13 180 Bearish Setup Bearish Swing Setup 6.98%
Nov 13 20 DMA Support Bullish 6.98%

Older signals for GALT ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Galectin Therapeutics Inc., a development stage company, engages in the development of therapies for cancer and fibrotic disease. Its lead product candidates include GR-MD-02, a complex polysaccharide polymer for the treatment of liver fibrosis and fatty liver disease for which the company intends to initiate a Phase I clinical trial in patients with non-alcoholic steatohepatitis; and GM-CT-01, a linear polysaccharide polymer comprising mannose and galactose that is in a Phase I/II clinical trial in Europe as a combination therapy with a tumor vaccine in patients with advanced melanoma. The company was formerly known as Pro-Pharmaceuticals, Inc. and changed its name to Galectin Therapeutics Inc. in May 2011. Galectin Therapeutics Inc. was founded in 2000 and is based in Norcross, Georgia.
Is GALT a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 2 bullish, 1 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 9.49
52 Week Low 1.28
Average Volume 501,795
200-Day Moving Average 4.9867
50-Day Moving Average 5.2034
20-Day Moving Average 4.669
10-Day Moving Average 4.892
Average True Range 0.4745
ADX 20.89
+DI 25.2773
-DI 17.6533
Chandelier Exit (Long, 3 ATRs ) 4.7365
Chandelier Exit (Short, 3 ATRs ) 5.2735
Upper Bollinger Band 5.4003
Lower Bollinger Band 3.9377
Percent B (%b) 0.77
BandWidth 31.325766
MACD Line -0.0529
MACD Signal Line -0.1039
MACD Histogram 0.051
Fundamentals Value
Market Cap 177.35 Million
Num Shares 35.1 Million
EPS -0.61
Price-to-Earnings (P/E) Ratio -8.30
Price-to-Sales 0.00
Price-to-Book 0.00
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 5.69
Resistance 3 (R3) 5.64 5.38 5.59
Resistance 2 (R2) 5.38 5.22 5.41 5.55
Resistance 1 (R1) 5.22 5.12 5.30 5.27 5.51
Pivot Point 4.96 4.96 5.00 4.99 4.96
Support 1 (S1) 4.80 4.80 4.88 4.85 4.61
Support 2 (S2) 4.54 4.70 4.57 4.57
Support 3 (S3) 4.38 4.54 4.54
Support 4 (S4) 4.43